IRIS
PINCHERA, BIAGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.631
NA - Nord America 3.445
EU - Europa 2.875
SA - Sud America 516
AF - Africa 130
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.273
SG - Singapore 1.851
RU - Federazione Russa 1.388
CN - Cina 999
VN - Vietnam 871
IT - Italia 641
BR - Brasile 417
HK - Hong Kong 277
DE - Germania 208
NL - Olanda 151
BD - Bangladesh 130
FR - Francia 128
JP - Giappone 113
CA - Canada 96
IN - India 89
GB - Regno Unito 88
KR - Corea 83
FI - Finlandia 64
AR - Argentina 43
IQ - Iraq 39
PL - Polonia 39
MX - Messico 37
ZA - Sudafrica 33
CI - Costa d'Avorio 29
UA - Ucraina 27
TH - Thailandia 26
ES - Italia 25
ID - Indonesia 22
AT - Austria 20
SE - Svezia 20
CO - Colombia 16
PH - Filippine 16
LT - Lituania 15
EC - Ecuador 14
EG - Egitto 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
IE - Irlanda 13
MA - Marocco 12
PK - Pakistan 12
TW - Taiwan 10
JM - Giamaica 9
TR - Turchia 9
DZ - Algeria 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
KE - Kenya 7
VE - Venezuela 7
CH - Svizzera 6
CL - Cile 6
TN - Tunisia 6
ET - Etiopia 5
JO - Giordania 5
LV - Lettonia 5
MY - Malesia 5
NI - Nicaragua 5
UY - Uruguay 5
AU - Australia 4
BG - Bulgaria 4
NZ - Nuova Zelanda 4
RO - Romania 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AL - Albania 3
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
LU - Lussemburgo 3
MD - Moldavia 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
DJ - Gibuti 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
LY - Libia 2
PR - Porto Rico 2
QA - Qatar 2
SR - Suriname 2
AM - Armenia 1
BS - Bahamas 1
BW - Botswana 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
Totale 11.584
Salva come PNG Salva come JPEG
Città #
Singapore 947
San Jose 660
Ashburn 431
Hefei 419
Moscow 360
Naples 261
Hong Kong 260
Ho Chi Minh City 240
Beijing 232
Hanoi 192
Los Angeles 141
Chandler 139
Santa Clara 139
The Dalles 123
Amsterdam 115
Tokyo 105
Munich 88
New York 87
Lauterbourg 82
Dallas 78
Seoul 74
São Paulo 50
Da Nang 45
Redondo Beach 43
Haiphong 40
Seattle 40
Council Bluffs 37
Rome 37
Boston 35
Buffalo 34
Frankfurt am Main 34
Lawrence 34
Millbury 34
Brooklyn 32
Orem 32
Warsaw 32
Montreal 30
Turku 29
Nuremberg 26
Des Moines 25
Milan 22
Baghdad 21
Houston 21
Chicago 20
Ottawa 20
Chennai 19
Helsinki 19
Napoli 19
Boardman 18
London 18
Denver 17
Mexico City 17
Rio de Janeiro 17
Toronto 17
Johannesburg 16
Stockholm 16
Poplar 15
Can Tho 14
Washington 14
Phoenix 13
Tashkent 13
Atlanta 12
Bangkok 12
Biên Hòa 12
Lappeenranta 12
Afragola 11
Charlotte 11
Manchester 11
Wilmington 11
Bologna 10
Düsseldorf 10
Hải Dương 10
Pozzuoli 10
Pune 10
Formia 9
Guarulhos 9
San Francisco 9
Belo Horizonte 8
Bengaluru 8
Brasília 8
Dublin 8
Guangzhou 8
Mumbai 8
Porto Alegre 8
Querétaro 8
Vienna 8
Boydton 7
Bắc Giang 7
Curitiba 7
Fisciano 7
Kingston 7
Kochi 7
Kronberg 7
Parma 7
Thái Nguyên 7
Tân Tiến 7
Bến Tre 6
Cairo 6
Caxias do Sul 6
Jakarta 6
Totale 6.543
Salva come PNG Salva come JPEG
Nome #
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection 193
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 185
Peri-transplant Treatment with Ceftaroline in Kidney Transplant Recipients at Risk of Donor-derived MRSA Infections: A Case Series 183
A transient increase in the serum ancas in patients with sars-cov-2 infection: A signal of subclinical vasculitis or an epiphenomenon with no clinical manifestations? a pilot study 179
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 178
Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives 175
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 173
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 159
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 156
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 156
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 153
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 151
Diabetes and COVID-19: The potential role of mTOR 150
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 149
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 148
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 146
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 143
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 143
Bulevirtide Treatment of Hepatitis Delta Virus Infection in a Kidney Transplant Recipient: A Case Report 143
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? 142
Further findings concerning endothelial damage in covid-19 patients 142
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 141
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 141
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study 140
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 139
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 139
Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients 139
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 138
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 138
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 137
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 137
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 136
Molecular fingerprint by omics‐based approaches in saliva from patients affected by SARS‐CoV‐2 infection 136
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 135
Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience 135
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 135
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 134
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 133
COVID-19 in solid organ transplant recipients after 2 years of pandemic: Outcome and impact of antiviral treatments in a single-center study 133
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 132
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study 131
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 131
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 131
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 130
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 130
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 129
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status 129
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 129
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 128
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 128
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 127
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 126
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 125
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 124
Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy? 123
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 122
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 122
No Detection of SARS-CoV-2 RNA on Urethral Swab in Patients with Positive Nasopharyngeal Swab 122
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 122
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 121
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 120
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 119
Update on the Management of Surgical Site Infections 118
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 118
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 116
Current evidence on the management of hepatitis B in pregnancy 116
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 115
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 114
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results 114
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients 113
Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia 113
Soluble urokinase receptor as a promising marker for early prediction of outcome in covid-19 hospitalized patients 112
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study 109
Effectiveness and Tolerability of Early Treatment with Monoclonal Antibodies against SARS-Cov-2: Results from A Real-Life Study before Omicron Surge 108
Urinary Tract Infections in Kidney Transplant Patients: An Open Challenge—Update on Epidemiology, Risk Factors and Management 107
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 106
Alzheimer's disease and herpes viruses: Current events and perspectives 103
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 102
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 98
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 95
Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy 93
Immune Profile in COVID-19: Unveiling TR3-56 Cells in SARS-CoV-2 Infection 86
COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment 82
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 80
Preventing sepsis development in complicated urinary tract infections 73
Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients 73
Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases 72
Infection prevention and control risk factors for SARS-CoV-2 infection in health workers: a global, multi-centre, case–control study 72
Personalized care approaches to hepatitis C therapy: recent advances and future directions 69
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 68
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension 66
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 58
Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy 54
Clinical Impact of Treating Versus Not Treating Asymptomatic Bacteriuria/Candiduria in the First Two Months After Kidney Transplantation 52
Urinary tract infections in kidney transplant patients admitted to hospital: A real-life experience 51
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study) 33
What Drives Mortality in S. maltophilia Bloodstream Infections? An Outcome-Focused Cohort Study of Treatment Strategies and Resistance Profiles 13
Uncovering hidden HCV infections in adults over 55: reflex testing and insights for opportunistic screening in a tertiary care setting 3
Totale 11.789
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.367
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022234 11 2 3 1 1 5 8 19 10 27 61 86
2022/2023548 37 22 22 23 63 79 27 62 71 104 28 10
2023/2024585 23 74 103 45 42 102 9 53 20 9 60 45
2024/20253.174 84 52 19 75 90 191 340 227 212 373 1.220 291
2025/20267.027 708 637 815 743 1.055 335 819 378 624 471 191 251
2026/202752 52 0 0 0 0 0 0 0 0 0 0 0
Totale 11.789